EquitiesIndia.com

Healthcare · Drug Manufacturers - Specialty & Generic

Gland Pharma Ltd.

GLAND

Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company also offers its products for various therapeutic categories, such as anti- diabetic, anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastro-intestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain/analgesics, respiratory and pulmonology, and vitamins, minerals, and nutrients. In addition, it provides contract development, dossier compilation, technology transfer services. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.

Key metrics

Market Cap

₹28,699 cr

P/E Ratio

33.88x

P/B Ratio

3.14x

ROE

7.63%

ROCE

11.62%

Debt / Equity

0.03x

Net Margin

12.51%

Dividend Yield

103%

EPS

₹42.4

Period

FY2025

Shareholding pattern

As of Latest
Promoter: 51.84%FII: 36.61%Public: 11.55%

Deep-dive pages

Educational content — not investment adviceThis page presents publicly available information about Gland Pharma Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.